FdaApplication
ANDA 212613
Identifiers
- fda_app_no: ANDA212613
Properties
| Property | Value |
|---|---|
| applicant_name | AMPHASTAR PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-04-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GANIRELIX ACETATE | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE;INJECTION |
1 product